Literature DB >> 3350970

Perinatal hypophosphatasia: tissue levels of vitamin B6 are unremarkable despite markedly increased circulating concentrations of pyridoxal-5'-phosphate. Evidence for an ectoenzyme role for tissue-nonspecific alkaline phosphatase.

M P Whyte1, J D Mahuren, K N Fedde, F S Cole, E R McCabe, S P Coburn.   

Abstract

"Perinatal" hypophosphatasia is the most severe form of this inborn error of metabolism, which is characterized by deficient activity of the tissue-nonspecific (liver/bone/kidney) isoenzyme of alkaline phosphatase (ALP) (TNSALP). We report that autopsy tissue from three affected subjects, which was profoundly low in ALP activity, had essentially unremarkable levels of pyridoxal-5'-phosphate (PLP), pyridoxal, and total vitamin B6 content despite markedly elevated plasma PLP levels (5,800, 14,500, and 98,500 nM; adult norm, 5-109 nM). Our findings help to explain the general absence of symptoms of vitamin B6 excess or deficiency in hypophosphatasia, and provide evidence that TNSALP acts as an ectoenzyme to regulate extracellular rather than intracellular concentrations of PLP (the cofactor form of vitamin B6) and perhaps other phosphate compounds.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3350970      PMCID: PMC329654          DOI: 10.1172/JCI113440

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  Intestinal alkaline phosphatase activity in familial hypophosphatasia.

Authors:  S H Danovitch; P N Baer; L Laster
Journal:  N Engl J Med       Date:  1968-06-06       Impact factor: 91.245

2.  A simple, rapid, and sensitive DNA assay procedure.

Authors:  C Labarca; K Paigen
Journal:  Anal Biochem       Date:  1980-03-01       Impact factor: 3.365

3.  A nuclear phosphatase that specifically hydrolyzes pyridoxal 5'-phosphate in mouse liver.

Authors:  A Kyaw
Journal:  Biochem Med       Date:  1980-08

4.  Selective localization of a Golgi apparatus acid phosphatase isoenzyme in bone using pyridoxal-5'-phosphate.

Authors:  R A Coleman; B H Schofield; D F McDonald
Journal:  J Histochem Cytochem       Date:  1980-02       Impact factor: 2.479

5.  Vitamin B6 deficiency in cancer patients.

Authors:  C Potera; D P Rose; R R Brown
Journal:  Am J Clin Nutr       Date:  1977-10       Impact factor: 7.045

6.  Role of phosphatidylinositol in attachment of alkaline phosphatase to membranes.

Authors:  M G Low; D B Zilversmit
Journal:  Biochemistry       Date:  1980-08-19       Impact factor: 3.162

Review 7.  Structural and functional roles of glycosyl-phosphatidylinositol in membranes.

Authors:  M G Low; A R Saltiel
Journal:  Science       Date:  1988-01-15       Impact factor: 47.728

8.  Stereospecific inhibition of alkaline phosphatase by L-tetramisole prevents in vitro cartilage calcification.

Authors:  M D Fallon; M P Whyte; S L Teitelbaum
Journal:  Lab Invest       Date:  1980-12       Impact factor: 5.662

Review 9.  Vitamin B6: an overview.

Authors:  C E Shideler
Journal:  Am J Med Technol       Date:  1983-01

10.  Hydrolysis of pyridoxal-5'-phosphate in plasma in conditions with raised alkaline phosphate.

Authors:  B B Anderson; H O'Brien; G E Griffin; D L Mollin
Journal:  Gut       Date:  1980-03       Impact factor: 23.059

View more
  31 in total

1.  Increased plasma pyridoxal-5'-phosphate levels before and after pyridoxine loading in carriers of perinatal/infantile hypophosphatasia.

Authors:  B N Chodirker; S P Coburn; L E Seargeant; M P Whyte; C R Greenberg
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  High-throughput screening of tissue-nonspecific alkaline phosphatase for identification of effectors with diverse modes of action.

Authors:  Eduard A Sergienko; José Luis Millán
Journal:  Nat Protoc       Date:  2010-07-15       Impact factor: 13.491

Review 3.  Direct and Functional Biomarkers of Vitamin B6 Status.

Authors:  Per Magne Ueland; Arve Ulvik; Luisa Rios-Avila; Øivind Midttun; Jesse F Gregory
Journal:  Annu Rev Nutr       Date:  2015-05-13       Impact factor: 11.848

4.  Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia.

Authors:  K N Fedde; L Blair; J Silverstein; S P Coburn; L M Ryan; R S Weinstein; K Waymire; S Narisawa; J L Millán; G R MacGregor; M P Whyte
Journal:  J Bone Miner Res       Date:  1999-12       Impact factor: 6.741

5.  Hypophosphatasia - pathophysiology and treatment.

Authors:  José Luis Millán; Horacio Plotkin
Journal:  Actual osteol       Date:  2012-09-01

6.  Alkaline phosphatase (tissue-nonspecific isoenzyme) is a phosphoethanolamine and pyridoxal-5'-phosphate ectophosphatase: normal and hypophosphatasia fibroblast study.

Authors:  K N Fedde; M P Whyte
Journal:  Am J Hum Genet       Date:  1990-11       Impact factor: 11.025

7.  Glu274Lys/Gly309Arg mutation of the tissue-nonspecific alkaline phosphatase gene in neonatal hypophosphatasia associated with convulsions.

Authors:  O Reish; T Dolfin; S Arnon; R Regev; G Grinshpan; M Yamazaki; K Ozono
Journal:  J Inherit Metab Dis       Date:  2002-02       Impact factor: 4.982

Review 8.  Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.

Authors:  Michael P Whyte
Journal:  Nat Rev Endocrinol       Date:  2016-02-19       Impact factor: 43.330

9.  Pseudohypophosphatasia: aberrant localization and substrate specificity of alkaline phosphatase in cultured skin fibroblasts.

Authors:  K N Fedde; D E Cole; M P Whyte
Journal:  Am J Hum Genet       Date:  1990-11       Impact factor: 11.025

10.  Alkaline phosphatase: placental and tissue-nonspecific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5'-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy.

Authors:  M P Whyte; M Landt; L M Ryan; R A Mulivor; P S Henthorn; K N Fedde; J D Mahuren; S P Coburn
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.